Emergent CEO sold more than $10 million in stock before scrapping J&J COVID-19 vaccine doses: report

Emergent CEO sold more than $10 million in stock before scrapping J&J COVID-19 vaccine doses: report
nhigginsdunn
Mon, 04/26/2021 – 11:32